A61K 31/4164 1,3-Diazoles
Introduced: January 2000
Last revised: January 2006
Full Title
Medicinal preparations containing organic active ingredients > Heterocyclic compounds > having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins > having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole > 1,3-Diazoles
Classification Context
- Section:
- HUMAN NECESSITIES
- Class:
- MEDICAL OR VETERINARY SCIENCE; HYGIENE
- Subclass:
- PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
Filing statistics
IPC A61K 31/4164 belongs to the parent subclass A61K, which recorded 1,792,627 patent applications worldwide between 2013 and 2023. Annual filings declined from 147,606 in 2013 to 132,650 in 2023 (-10%), peaking at 177,518 applications in 2016. The most active applicants in class A61 are PHILIPS ELECTRONICS (18,523 applications), NOVARTIS (14,253 applications) and COVIDIEN (13,953 applications).
Source: EPO PATSTAT, worldwide filings
8 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- A61K 31/4166 having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
- A61K 31/4168 having a nitrogen atom attached in position 2, e.g. clonidine
- A61K 31/417 Imidazole-alkylamines, e.g. histamine, phentolamine
- A61K 31/4172 Imidazole-alkanecarboxylic acids, e.g. histidine
- A61K 31/4174 Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
- A61K 31/4178 not condensed and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
- A61K 31/4184 condensed with carbocyclic rings, e.g. benzimidazoles
- A61K 31/4188 condensed with heterocyclic ring systems, e.g. biotin, sorbinil
Top Applicants
Top 10 applicants by patent filingsfor class A61, 2013–2023, worldwide · Source: EPO PATSTAT
- PHILIPS ELECTRONICS NL 18,523
- NOVARTIS CH 14,253
- COVIDIEN US 13,953
- ROCHE CH 12,005
- CHINESE ACADEMY OF SCIENCES 11,955
- UNIVERSITY OF CALIFORNIA US 11,692
- HARVARD UNIVERSITY US 11,596
- L'OREAL FR 11,593
- P&G (PROCTER & GAMBLE COMPANY) US 11,297
- OLYMPUS CORPORATION JP 9,594